Skip to Content

Newsroom

Study Details First Therapeutic Melanoma Vaccine

Cancer Newsline - 06/06/2011

Scientists, led by Patrick Hwu, M.D., of MD Anderson Cancer Center, and Douglas Schwartzentruber, M.D., of Goshen Center for Cancer Care, have developed a vaccine for advanced melanoma. When combined with Interleuken-2, the cocktail stimulates the body’s immune system to recognize and ultimately fight cancer cells. Drs. Hwu and Schwartzentruber explain their findings, which are published in the New England Journal of Medicine, and discuss other recent advances in the treatment and research of this aggressive disease.

Guests: Patrick Hwu, M.D. and Douglas Schwartzentruber, M.D.


© 2014 The University of Texas MD Anderson Cancer Center